Cortical interneuron loss and symptom heterogeneity in Huntington disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Neurology

• Publication date

  2014-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/ana.24162PMID 24771513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor Cortex

  2013cited by this paper
• Huntington disease

  2010cited by this paper
• Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

  2010cited by this paper
• Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease

  2009cited by this paper
• Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

  2008cited by this paper
• Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

  2008cited by this paper
• GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression

  2007cited by this paper
• Striosomes and mood dysfunction in Huntington's disease.

  2007cited by this paper
• The Primary Motor and Premotor Areas of the Human Cerebral Cortex

  2006cited by this paper
• Immunohistochemical staining of post-mortem adult human brain sections

  2006cited by this paper
• Monozygotic twins discordant for Huntington disease after 7 years.

  2005cited by this paper
• Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

  2005cited by this paper
• Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.

  2005cited by this paper
• Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex.

  2005cited by this paper
• CHAPTER 26 – MOTOR CORTEX

  2004cited by this paper
• Calcium binding proteins and neuropeptides as molecular markers of GABAergic interneurons in the cat visual cortex

  2004cited by this paper
• Interneurons of the neocortical inhibitory system

  2004cited by this paper
• Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia

  2003cited by this paper
• Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.

  2002cited by this paper
• Pyramidal cell loss in motor cortices in Huntington's disease.

  2002cited by this paper
• Behavior in Huntington's disease: dissociating cognition-based and mood-based changes.

  2002cited by this paper
• Cortical interneurons: from Cajal to 2001.

  2002cited by this paper
• GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder

  2001cited by this paper
• Primate anterior cingulate cortex: Where motor control, drive and cognition interface

  2001cited by this paper
• Chandelier cells and epilepsy.

  1999cited by this paper
• Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease

  1999cited by this paper
• Huntington disease.

  1998cited by this paper
• Double bouquet cell axons in the human temporal neocortex: relationship to bundles of myelinated axons and colocalization of calretinin and calbindin D-28k immunoreactivities.

  1997cited by this paper
• Calretinin neurons in human medial prefrontal cortex (areas 24a,b,c, 32′, and 25)

  1997cited by this paper
• Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.

  1996cited by this paper
• Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex.

  1996cited by this paper
• Colocalization of calbindin D‐28k, calretinin, and GABA immunoreactivities in neurons of the human temporal cortex

  1996cited by this paper
• Contributions of anterior cingulate cortex to behaviour.

  1995cited by this paper
• Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease.

  1995cited by this paper
• Local circuit neurons immunoreactive for calretinin, calbindin D‐28k or parvalbumin in monkey prefronatal cortex: Distribution and morphology

  1994cited by this paper
• Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs.

  1992cited by this paper
• Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions.

  1992cited by this paper
• Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.

  1991cited by this paper
• Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

  1991cited by this paper
• Factors associated with slow progression in Huntington's disease.

  1991cited by this paper
• Unbiased stereological estimation of the number of neurons in the human hippocampus

  1990cited by this paper
• Loss of matrix calcium-binding protein-containing neurons in Huntington's disease.

  1988cited by this paper
• Differential loss of striatal projection neurons in Huntington disease.

  1988cited by this paper

• Aberrant medial ganglionic eminence (MGE) GABAergic neurogenesis contributes to Huntington's disease pathogenesis.

  2026cites this paper
• From Balance to Breakdown: striatal PV interneurons in Huntington’s disease and Autism Spectrum Disorder

  2026cites this paper
• Huntingtin inclusion bodies have distinct immunophenotypes and ubiquitination profiles in the Huntington’s disease human cerebral cortex

  2025cites this paper
• Prefrontal parvalbumin neurons as a target for enhancing cognition in non-pathological and 22q11.2 microdeletion syndrome mice

  2025cites this paper
• Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington’s Disease mice

  2025cites this paper
• Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays.

  2025cites this paper
• Neural Correlates of Huntington’s Disease Based on Electroencephalography (EEG): A Mechanistic Review and Discussion of Excitation and Inhibition (E/I) Imbalance

  2025cites this paper
• Synaptic mitochondria in aging and neurodegenerative diseases: unraveling their functional decline and vulnerability.

  2025cites this paper
• VEGF family in cortical development

  2025cites this paper
• Brain-Derived Neurotrophic Factor (BDNF) in Huntington’s Disease: Neurobiology and Therapeutic Potential

  2024cites this paper
• Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex.

  2024cites this paper
• Selective vulnerability of layer 5a corticostriatal neurons in Huntington's disease.

  2024cites this paper
• Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease.

  2024cites this paper
• Synaptic Mitochondria: a crucial factor in the aged hippocampus.

  2024cites this paper
• Pain in Huntington’s disease and its potential mechanisms

  2023cites this paper
• Age- and region-dependent cortical excitability in the zQ175 Huntington disease mouse model.

  2023cites this paper
• Selective Vulnerability of Layer 5a Corticostriatal Neurons in Huntington’s Disease

  2023cites this paper
• From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research

  2023cites this paper
• Selective perforant‐pathway atrophy in Huntington disease: MRI analysis of hippocampal subfields

  2023cites this paper
• Effects of medial prefrontal transcranial alternating current stimulation on neural activity and connectivity in people with Huntington's disease and neurotypical controls.

  2023cites this paper
• Editorial: New insight into Huntington's disease: From neuropathology to possible therapeutic targets

  2023cites this paper
• Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease

  2023cites this paper
• Medial prefrontal transcranial alternating current stimulation for apathy in Huntington's disease

  2022cites this paper
• Dysregulated cortical synaptic plasticity under methyl-CpG binding protein 2 deficiency and its implication in motor impairments

  2022cites this paper
• N-terminal mutant Huntingtin deposition correlates with CAG repeat length and disease onset, but not neuronal loss in Huntington’s disease

  2022cites this paper
• N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease.

  2022cites this paper
• Distinct histological alterations of cortical interneuron types in mouse models of Huntington’s disease

  2022influential citation
• Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes

  2022cites this paper
• Preparation, construction and high-throughput automated analysis of human brain tissue microarrays for neurodegenerative disease drug development

  2021cites this paper
• Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.

  2021cites this paper
• Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway

  2021cites this paper
• The human motor cortex microcircuit: insights for neurodegenerative disease

  2020cites this paper
• Synaptic Dysfunction in Huntington’s Disease: Lessons from Genetic Animal Models

  2020cites this paper
• Isolation and culture of functional adult human neurons from neurosurgical brain specimens

  2020cites this paper
• Cortical and Striatal Circuits in Huntington’s Disease

  2020cites this paper
• Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.

  2019cites this paper
• Cerebellar degeneration correlates with motor symptoms in Huntington disease

  2019cites this paper
• Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks

  2019influential citation
• Alterations in synaptic function and plasticity in Huntington disease

  2019cites this paper
• Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders

  2019cites this paper
• Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens

  2019cites this paper
• Homeostatic plasticity in neuronal cultures from the YAC128 Huntington disease model mouse

  2019cites this paper
• The Role of Microglia and Astrocytes in Huntington’s Disease

  2019cites this paper
• Understanding mechanistic regulation of Hsp70 and Hsp90 in neurodegenerative diseases.

  2019cites this paper
• Stereological Methods to Quantify Cell Loss in the Huntington's Disease Human Brain.

  2018cites this paper
• Cortical circuit alterations precede disease onset in Huntington’s disease mice

  2018cites this paper
• A critical review of brain and cognitive reserve in Huntington's disease

  2018influential citation
• Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease

  2018cites this paper
• Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington’s Disease

  2018cites this paper
• Therapeutic approaches to Huntington disease: from the bench to the clinic

  2018cites this paper
• Overlap between age-at-onset and disease-progression determinants in Huntington disease

  2018cites this paper
• Pathoarchitectonics of the cerebral cortex in chorea‐acanthocytosis and Huntington's disease

  2018cites this paper
• Epilepsy in Other Neurodegenerative Disorders: Huntington’s and Parkinson’s Diseases

  2017cites this paper
• Alterations of Synaptic Function in Huntington's Disease

  2017cites this paper
• Anatomy of the Cerebral Cortex

  2017cites this paper
• The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.

  2017cites this paper
• 6 Huntington’s Disease and Stem Cells

  2017cites this paper
• Neuroendocrine and Neurotrophic Signaling in Huntington ’ s Disease : Implications for Pathogenic Mechanisms and Treatment Strategies *

  2016cites this paper
• Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex.

  2016cites this paper
• Stereological approaches to dementia research using human brain tissue.

  2016cites this paper
• Cortico-Basal Ganglia Interactions in Huntington’s Disease

  2016cites this paper
• Globus pallidus degeneration and clinicopathological features of Huntington disease

  2016cites this paper
• Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

  2016cites this paper
• Neuroendocrine and neurotrophic signaling in Huntington's disease: Implications for pathogenic mechanisms and treatment strategies.

  2016cites this paper
• Induction of specific neuron types by overexpression of single transcription factors

  2016cites this paper
• Comparison of Huntington’s disease CAG Repeat Length Stability in Human Motor Cortex and Cingulate Gyrus

  2016cites this paper
• Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington’s disease

  2016cites this paper
• The clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease

  2015cites this paper
• Cortical Efferents Lacking Mutant huntingtin Improve Striatal Neuronal Activity and Behavior in a Conditional Mouse Model of Huntington's Disease

  2015cites this paper
• Comparative density of CCK- and PV-GABA cells within the cortex and hippocampus

  2015cites this paper
• Alterations of Thalamostriatal and Corticostriatal Projections in Mouse Models of Huntington’s Disease

  2015cites this paper
• Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity

  2015cites this paper
• Region-specific interneuronal degeneration in the human cerebral cortex in Huntington’s disease correlates with symptomatology

  2015influential citation
• Dissecting inhibitory brain circuits with genetically-targeted technologies

  2014cites this paper
• Characterising the structural brain changes in Huntington’s disease using translational neuroimaging

  2014cites this paper